Acknowledgements The authors also acknowledge Professor Mingxiang Zhang from the Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese Ministry of Health and Chinese Academy of Medical Sciences, Department of Cardiology, for assisting in experimental design and guidance
Purity: 98.88% CAS No.: 27025-41-8 Formula: C 20 H 32 N 6 O 12 S 2 Molecular Weight:612.63 Storage: Sealed storage, away from moisture
Biochem J (1994) 304(Pt 3):9815
However, limited studies have been conducted to understand the complete mechanisms of IGF-1 involved in cell proliferation and migration
doi: 10.1186/1476-511X-13-78 255 SimopoulosAP
Conservative starting doses would be essential: Initial phase : Cagrilintide 0.3 mg + Tirzepatide 2.5 mg weekly Escalation : Increase cagrilintide by 0.3-0.6 mg every 4 weeks Tirzepatide adjustment : Maintain or modestly increase based on tolerance Monitoring : Close observation for cumulative GI effects This remains speculative, as no published trials have examined this specific combination
